FDA NDC Directory · JSON-LD · Markdown

CaroSpir

NDC 46287-020 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerCMP Pharma, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA209478
Dosage form / routeSUSPENSION · ORAL
Active ingredientsSPIRONOLACTONE (25 mg/5mL)
Marketing started20170804
Package count3

External sources

Source: openFDA. Public-domain (CC0).